Phase I/II Trial of Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Conditions: Cervical Cancer; HPV Cancers; Anal Cancer; Oropharyngeal Cancer; Vulvar, Vaginal, Penile, Rectal Cancer Interventions: Biological: PDS0101; Biological: M7824; Biological: NHS-IL12 Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2020 Category: Research Source Type: clinical trials
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Conditions: Cervical Cancer; HPV Cancers; Anal Cancer; Oropharyngeal Cancer; Vulvar, Vaginal, Penile, Rectal Cancer Interventions: Biological: PDS0101; Biological: M7824; Biological: NHS-IL12 Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2020 Category: Research Source Type: clinical trials